China Everbright Narrows Operating Strain but 2025 Losses Deepen on Impairments

China Everbright ( (HK:0165) ) just unveiled an update.

China Everbright Limited reported consolidated turnover of HK$8.29 billion for 2025, up from HK$6.55 billion a year earlier, driven mainly by stronger dividend income and a swing to positive net income from investments. Despite the revenue growth and improved performance from associates and joint ventures, the group remained loss-making, posting a basic and diluted loss per share of HK$1.191 as impairment losses and unrealised investment losses continued to weigh on results.

The company recorded a net loss attributable to equity shareholders of HK$2.01 billion for 2025, slightly worse than the prior year, even as finance costs declined and non-controlling interests moved back into profit. The figures underscore ongoing pressure on the firm’s investment portfolio quality and valuation, suggesting that while topline and investment income have improved, asset impairments and market volatility still constrain profitability and may continue to shape investor sentiment and capital allocation decisions.

The most recent analyst rating on (HK:0165) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on China Everbright stock, see the HK:0165 Stock Forecast page.

More about China Everbright

China Everbright Limited is a Hong Kong–incorporated investment and financial services company listed on the Stock Exchange of Hong Kong. The group engages in asset management and various investment activities, generating income from contracts with customers, interest, dividends and proprietary investment portfolios across multiple sectors and instruments.

Average Trading Volume: 5,980,420

Technical Sentiment Signal: Sell

Current Market Cap: HK$12.89B

See more insights into 0165 stock on TipRanks’ Stock Analysis page.